Drug General Information (ID: D1511)
  Drug Name
Sucralfate
  Drug Type Small molecule
  Drug Synonymous
SUL; Ulcerlmin; Sucralfate, Chugai; Sucralfate, Scios Nova
    Click to Show/Hide
  Disease Class ED80: Acne vulgaris
  Therapeutic Class Gi Agents
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula C12H54Al9O55S8
  InChI 1S/C12H22O35S8.9Al.20H2O/c13-48(14,15)37-1-4-6(43-51(22,23)24)8(45-53(28,29)30)9(46-54(31,32)33)11(40-4)42-12(3-39-50(19,20)21)10(47-55(34,35)36)7(44-52(25,26)27)5(41-12)2-38-49(16,17)18;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/h4-11H,1-3H2,(H,13,14,15)(H,16,17,18)(H,19,20,21)(H,22,23,24)(H,25,26,27)(H,28,29,30)(H,31,32,33)(H,34,35,36);;;;;;;;;;20*1H2/q;;8*+1;;;;;;;;;;;;;;;;;;;;/p-8/t4-,5-,6-,7-,8+,9-,10+,11-,12+;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/m1............................./s1
  InChIKey YZPQNHUVIVIUCT-JTJNLBSYSA-F
  Canonical SMILES C(C1C(C(C(C(O1)OC2(C(C(C(O2)COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al].O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al]
  External Link
Pubchem ID 121494085
CAS Number 54182-58-0
TTD ID D06ULU

Drug-Drug Interaction Network
  Sunburst Graph
AM001  Affected gastrointestinal absorption
BM003  Complex formation
BM004  Adsorption
BM009  Altered absorption (Unspecific)
  Relation Graph
 Full list of drugs interacting with Sucralfate
      Affected gastrointestinal absorption
   Complex formation Drug Num:  59
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0181
 
Bictegravir
 
C21H18F3N3O5
 
90311989 
Major    Inter Info   
[1], [2], [3]
D0515
 
Dolutegravir
 
C20H19F2N3O5
 
54726191 
Major    Inter Info   
[4]
D0402
 
Cyclosporine
 
C62H111N11O12
 
5284373 
Moderate    Inter Info   
[7]
D0530
 
Doxycycline
 
C22H24N2O8
 
54671203 
Moderate    Inter Info   
[8], [9], [10]
D1092
 
Moxifloxacin
 
C21H24FN3O4
 
152946 
Moderate    Inter Info   
[11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42]
D1283
 
Phenytoin
 
C15H12N2O2
 
1775 
Moderate    Inter Info   
[9], [10], [43]
D0034
 
Alendronic acid
 
C4H13NO7P2
 
2088 
Moderate    Inter Info   
[44], [45], [46]
D0144
 
Baloxavir marboxil
 
C27H23F2N3O7S
 
124081896 
Moderate    Inter Info   
[48]
D0310
 
Chenodeoxycholic acid
 
C24H40O4
 
10133 
Moderate    Inter Info   
[49]
D0330
 
Cholic Acid
 
C24H40O5
 
221493 
Moderate    Inter Info   
[50]
D0340
 
Cinoxacin
 
C12H10N2O5
 
2762 
Moderate    Inter Info   
[11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42]
D0341
 
Ciprofloxacin
 
C17H18FN3O3
 
2764 
Moderate    Inter Info   
[11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42]
D0432
 
Deferasirox
 
C21H15N3O4
 
214348 
Moderate    Inter Info   
[51]
D0433
 
Deferiprone
 
C7H9NO2
 
2972 
Moderate    Inter Info   
[1], [2], [52]
D0438
 
Delafloxacin
 
C18H12ClF3N4O4
 
487101 
Moderate    Inter Info   
[11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42]
D0490
 
Digitoxin
 
C41H64O13
 
441207 
Moderate    Inter Info   
[9], [10], [53]
D0491
 
Digoxin
 
C41H64O14
 
2724385 
Moderate    Inter Info   
[9], [10], [53]
D0573
 
Enoxacin
 
C15H17FN4O3
 
3229 
Moderate    Inter Info   
[11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42]
D0704
 
Furosemide
 
C12H11ClN2O5S
 
3440 
Moderate    Inter Info   
[2], [54]
D0712
 
Gatifloxacin
 
C19H22FN3O4
 
5379 
Moderate    Inter Info   
[11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42]
D0716
 
Gemifloxacin
 
C18H20FN5O4
 
9571107 
Moderate    Inter Info   
[11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42]
D0740
 
Grepafloxacin
 
C19H22FN3O3
 
72474 
Moderate    Inter Info   
[11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42]
D0783
 
Ibandronate
 
C9H23NO7P2
 
60852 
Moderate    Inter Info   
[55], [56], [44], [45], [57], [46]
D0919
 
Levofloxacin
 
C18H20FN3O4
 
149096 
Moderate    Inter Info   
[11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42]
D0943
 
Lomefloxacin
 
C17H19F2N3O3
 
3948 
Moderate    Inter Info   
[11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42]
D1003
 
Mephenytoin
 
C12H14N2O2
 
4060 
Moderate    Inter Info   
[9], [10], [43]
D1070
 
Minocycline
 
C23H27N3O7
 
54675783 
Moderate    Inter Info   
[8], [9], [10]
D1102
 
Nalidixic acid
 
C12H12N2O3
 
4421 
Moderate    Inter Info   
[58]
D1155
 
Norfloxacin
 
C16H18FN3O3
 
4539 
Moderate    Inter Info   
[11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42]
D1165
 
Ofloxacin
 
C18H20FN3O4
 
4583 
Moderate    Inter Info   
[11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42]
D1175
 
Omadacycline
 
C29H40N4O7
 
54697325 
Moderate    Inter Info   
[8], [9], [10]
D1245
 
Penicillamine
 
C5H11NO2S
 
5852 
Moderate    Inter Info   
[59], [60], [61], [62], [63], [64], [65], [32]
D1369
 
Quinapril
 
C25H30N2O5
 
54892 
Moderate    Inter Info   
[2], [54]
D1412
 
Risedronic acid
 
C7H11NO7P2
 
5245 
Moderate    Inter Info   
[44], [45], [46]
D1445
 
Sarecycline
 
C24H29N3O8
 
54681908 
Moderate    Inter Info   
[8], [9], [10]
D1499
 
Sparfloxacin
 
C19H22F2N4O3
 
60464 
Moderate    Inter Info   
[11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42]
D1564
 
Tetracycline
 
C22H24N2O8
 
54675776 
Moderate    Inter Info   
[8], [9], [10]
D1584
 
Tiludronic acid
 
C7H9ClO6P2S
 
60937 
Moderate    Inter Info   
[45], [66], [46]
D1657
 
Trovafloxacin
 
C20H15F3N4O3
 
62959 
Moderate    Inter Info   
[11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42]
D0117
 
Atenolol
 
C14H22N2O3
 
2249 
Minor    Inter Info   
[67], [68], [69], [70], [71], [72], [73]
D0173
 
Betaxolol
 
C18H29NO3
 
2369 
Minor    Inter Info   
[67], [68], [69], [70], [71], [72], [73]
D0934
 
Liothyronine
 
C15H12I3NO4
 
5920 
Minor    Inter Info   
[74], [75]
D1049
 
Metoprolol
 
C15H25NO3
 
4171 
Minor    Inter Info   
[67], [68], [69], [70], [71], [72], [73]
D0010
 
Acebutolol
 
C18H28N2O4
 
1978 
Minor    Inter Info   
[67], [68], [69], [70], [71], [72], [73]
D0188
 
Bisoprolol
 
C18H31NO4
 
2405 
Minor    Inter Info   
[67], [68], [69], [70], [71], [72], [73]
D0265
 
Carteolol
 
C16H24N2O3
 
2583 
Minor    Inter Info   
[67], [68], [69], [70], [71], [72], [73]
D0267
 
Carvedilol
 
C24H26N2O4
 
2585 
Minor    Inter Info   
[67], [68], [69], [70], [71], [72], [73]
D0884
 
Labetalol
 
C19H24N2O3
 
3869 
Minor    Inter Info   
[67], [68], [69], [70], [71], [72], [73]
D0925
 
Levothyroxine
 
C15H11I4NO4
 
5819 
Minor    Inter Info   
[74], [75]
D0935
 
Liotrix
 
C30H21I7N2Na2O8
 
71371 
Minor    Inter Info   
[74], [75]
D1098
 
Nadolol
 
C17H27NO4
 
39147 
Minor    Inter Info   
[67], [68], [69], [70], [71], [72], [73]
D1109
 
Naproxen
 
C14H14O3
 
156391 
Minor    Inter Info   
[89], [1], [2], [90]
D1114
 
Nebivolol
 
C22H25F2NO4
 
71301 
Minor    Inter Info   
[67], [68], [69], [70], [71], [72], [73]
D1244
 
Penbutolol
 
C18H29NO2
 
37464 
Minor    Inter Info   
[67], [68], [69], [70], [71], [72], [73]
D1293
 
Pindolol
 
C14H20N2O2
 
4828 
Minor    Inter Info   
[67], [68], [69], [70], [71], [72], [73]
D1357
 
Propranolol
 
C16H21NO2
 
4946 
Minor    Inter Info   
[67], [68], [69], [70], [71], [72], [73]
D1498
 
Sotalol
 
C12H20N2O3S
 
5253 
Minor    Inter Info   
[67], [68], [69], [70], [71], [72], [73]
D1577
 
Thyroid, porcine
 
NA
 
NA
Minor    Inter Info   
[74], [75], [91]
D1585
 
Timolol
 
C13H24N4O3S
 
33624 
Minor    Inter Info   
[67], [68], [69], [70], [71], [72], [73]
   Adsorption Drug Num:  15
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0037
 
Alimemazine
 
C18H22N2S
 
5574 
Minor    Inter Info   
[76], [77], [78]
D0324
 
Chlorpromazine
 
C17H19ClN2S
 
2726 
Minor    Inter Info   
[76], [77], [79], [80], [78]
D0678
 
Fluphenazine
 
C22H26F3N3OS
 
3372 
Minor    Inter Info   
[76], [77], [79], [80], [78]
D1010
 
Mesoridazine
 
C21H26N2OS2
 
4078 
Minor    Inter Info   
[76], [77], [79], [80], [78]
D1019
 
Methdilazine
 
C18H20N2S
 
14677 
Minor    Inter Info   
[76], [77], [79], [80], [78]
D1026
 
Methotrimeprazine
 
C19H24N2OS
 
72287 
Minor    Inter Info   
[76], [77], [79], [80], [78]
D1257
 
Perphenazine
 
C21H26ClN3OS
 
4748 
Minor    Inter Info   
[76], [77], [79], [80], [78]
D1346
 
Prochlorperazine
 
C20H24ClN3S
 
4917 
Minor    Inter Info   
[76], [77], [79], [80], [78]
D1351
 
Promazine
 
C17H20N2S
 
4926 
Minor    Inter Info   
[76], [77], [79], [80], [78]
D1352
 
Promethazine
 
C17H20N2S
 
4927 
Minor    Inter Info   
[76], [77], [79], [80], [78]
D1355
 
Propiomazine
 
C20H24N2OS
 
4940 
Minor    Inter Info   
[76], [77], [79], [80], [78]
D1572
 
Thiethylperazine
 
C22H29N3S2
 
5440 
Minor    Inter Info   
[76], [77], [79], [80], [78]
D1574
 
Thioridazine
 
C21H26N2S2
 
5452 
Minor    Inter Info   
[76], [77], [79], [80], [78]
D1637
 
Trifluoperazine
 
C21H24F3N3S
 
5566 
Minor    Inter Info   
[76], [77], [79], [80], [78]
D1638
 
Triflupromazine
 
C18H19F3N2S
 
5568 
Minor    Inter Info   
[76], [77], [79], [80], [78]
   Altered absorption (Unspecific) Drug Num:  8
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0527
 
Doxercalciferol
 
C28H44O2
 
5281107 
Major    Inter Info   
[2], [5]
D1226
 
Paricalcitol
 
C27H44O3
 
5281104 
Major    Inter Info   
[2], [5]
D0111
 
Ascorbic acid
 
C6H8O6
 
54670067 
Moderate    Inter Info   
[2], [6]
D0040
 
Allopurinol
 
C5H4N4O
 
135401907 
Moderate    Inter Info   
[1], [2], [47]
D0476
 
Diclofenac
 
C14H11Cl2NO2
 
3033 
Minor    Inter Info   
[81]
D0489
 
Diflunisal
 
C13H8F2O3
 
3059 
Minor    Inter Info   
[67], [82], [83]
D0858
 
Isoniazid
 
C6H7N3O
 
3767 
Minor    Inter Info   
[84], [85]
D0880
 
Ketoconazole
 
C26H28Cl2N4O4
 
456201 
Minor    Inter Info   
[86], [87], [88]
References
1 Cerner Multum, Inc. "Australian Product Information.".
2 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
3 Product Information. Biktarvy (bictegravir/emtricitabine/tenofovir). Gilead Sciences, Foster City, CA.
4 Product Information. Tivicay (dolutegravir). ViiV Healthcare, Research Triangle Park, NC.
5 Product Information. Zemplar (paricalcitol). Abbott Pharmaceutical, Abbott Park, IL.
6 Fairweather-Tait S, Hickson K, McGaw B, Reid M "Orange juice enhances aluminium absorption from antacid preparation." Eur J Clin Nutr 48 (1994): 71-3. [PMID: 8200332]
7 Ichisawa M, Ohta I, Suzuki R, et al. "The effect of dried aluminum hydroxide gel on the blood concentration of cyclosporine-A." Jpn J Hosp Pharm 23 (1997): 407-13.
8 Cerner Multum, Inc. "Canadian Product Information.".
9 McCarthy DM "Sucralfate." N Engl J Med 325 (1991): 1017-25. [PMID: 1886624]
10 Product Information. Carafate (sucralfate). Hoechst Marion-Roussel Inc, Kansas City, MO.
11 Akerele JO, Okhamafe AO "Influence of oral co-administered metallic drugs on ofloxacin pharmacokinetics." J Antimicrob Chemother 28 (1991): 87-94. [PMID: 1663108]
12 Allen A, Vousden M, Porter A, Lewis A "Effect of Maalox((R)) on the bioavailability of oral gemifloxacin in healthy volunteers." Chemotherapy 45 (1999): 504-11. [PMID: 10567782]
13 Campbell NR, Kara M, Hasinoff BB, Haddara WM, McKay DW "Norfloxacin interaction with antacids and minerals." Br J Clin Pharmacol 33 (1992): 115-6. [PMID: 1540482]
14 Frost RW, Lasseter KC, Noe AJ, Shamblen EC, Lettieri JT "Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin." Antimicrob Agents Chemother 36 (1992): 830-2. [PMID: 1503446]
15 Garrelts JC, Godley PJ, Peterie JD, Gerlach EH, Yakshe CC "Sucralfate significantly reduces ciprofloxacin concentrations in serum." Antimicrob Agents Chemother 34 (1990): 931-3. [PMID: 2360833]
16 Grasela TH Jr, Schentag JJ, Sedman AJ, et al "Inhibition of enoxacin absorption by antacids or ranitidine." Antimicrob Agents Chemother 33 (1989): 615-7. [PMID: 2751276]
17 Honig PK, Gillespie BK "Clinical significance of pharmacokinetic drug interactions with over-the-counter (OTC) drugs." Clin Pharmacokinet 35 (1998): 167-71. [PMID: 9784931]
18 Johnson RD, Dorr MB, Talbot GH, Caille G "Effect of Maalox on the oral absorption of sparfloxacin." Clin Ther 20 (1998): 1149-58. [PMID: 9916608]
19 Kamberi M, Nakashima H, Ogawa K, Oda N, Nakano S "The effect of staggered dosing of sucralfate on oral bioavailability of sparfloxacin." Br J Clin Pharmacol 49 (2000): 98-103. [PMID: 10671902]
20 Lehto P, Kivisto KT "Different effects of products containing metal ions on the absorption of lomefloxacin." Clin Pharmacol Ther 56 (1994): 477-82. [PMID: 7955811]
21 Lehto P, Kivisto KT "Effect of sucralfate on absorption of norfloxacin and ofloxacin." Antimicrob Agents Chemother 38 (1994): 248-51. [PMID: 8192452]
22 Lober S, Ziege S, Rau M, Schreiber G, Mignot A, Koeppe P, Lode H "Pharmacokinetics of gatifloxacin and interaction with an antacid containing aluminum and magnesium." Antimicrob Agents Chemother 43 (1999): 1067-71. [PMID: 10223915]
23 Nix DE, Watson WA, Lener ME, et al "Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin." Clin Pharmacol Ther 46 (1989): 700-5. [PMID: 2598571]
24 Nix DE, Wilton JH, Ronald B, Distlerath L, Williams VC, Norman A "Inhibition of norfloxacin absorption by antacids." Antimicrob Agents Chemother 34 (1990): 432-5. [PMID: 2334155]
25 Noyes M, Polk RE "Norfloxacin and absorption of magnesium-aluminum." Ann Intern Med 109 (1988): 168-9. [PMID: 3382110]
26 Parpia SH, Nix DE, Hejmanowski LG, Goldstein HR, Wilton JH, Schentag JJ "Sucralfate reduces the gastrointestinal absorption of norfloxacin." Antimicrob Agents Chemother 33 (1989): 99-102. [PMID: 2712548]
27 Polk RE, Helay DP, Sahai J, Drwal L, Racht E "Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers." Antimicrob Agents Chemother 33 (1989): 1841-4. [PMID: 2610494]
28 Product Information. Baxdela (delafloxacin). Melinta Therapeutics, Lincolnshire, IL.
29 Product Information. Factive (gemifloxacin). GeneSoft Inc, San Francisco, CA.
30 Product Information. Levaquin (levofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
31 Product Information. Raxar (grepafloxacin). Glaxo Wellcome, Research Triangle Park, NC.
32 Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
33 Product Information. Trovan (trovafloxacin). Pfizer US Pharmaceuticals, New York, NY.
34 Product Information. Zagam (sparfloxacin). Rhone-Poulenc Rorer, Collegeville, PA.
35 Sahai J, Healy DP, Stotka J, Polk RE "The influence of chronic administration of calcium carbonate on the bioavailability of oral ciprofloxacin." Br J Clin Pharmacol 35 (1993): 302-4. [PMID: 8471407]
36 Shimada J, Shiba K, Oguma T, et al "Effect of antacid on absorption of the quinolone lomefloxacin." Antimicrob Agents Chemother 36 (1992): 1219-24. [PMID: 1329615]
37 Spivey JM, Cummings DM, Pierson NR "Failure of prostatitis treatment secondary to probable ciprofloxacin-sucralfate drug interaction." Pharmacotherapy 16 (1996): 314-6. [PMID: 8820479]
38 Teng R, Dogolo LC, Willavize SA, Friedman HL, Vincent J "Effect of Maalox and omeprazole on the bioavailability of trovafloxacin." J Antimicrob Chemother 39 Suppl B (1997): 93-7. [PMID: 9222077]
39 Wadworth AN, Goa KL "Lomefloxacin: a review of its antibacterial activity, pharmacokinetic properties and therapeutic use." Drugs 42 (1991): 1018-60. [PMID: 1724637]
40 Yuk JH "Ciprofloxacin levels when receiving sucralfate." J Am Geriatr Soc 262 (1989): 901. [PMID: 2754785]
41 Zix JA, Geerdes-Fenge HF, Rau M, Vockler J, Borner K, Koeppe P, Lode H "Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate." Antimicrob Agents Chemother 41 (1997): 1668-72. [PMID: 9257738]
42 Deppermann KM, Lode H, Hoffken G, Tschink G, Kalz C, Koeppe P "Influence of ranitidine, pirenzepine, and aluminum magnesium hydroxide on the bioavailability of various antibiotics, including amoxicillin, cephalexin, doxycycline, and amoxicillin-clavulanic acid." Antimicrob Agents Chemother 33 (1989): 1901-7. [PMID: 2610502]
43 Smart HL, Somerville KW, Williams J, et al "The effects of sucralfate upon phenytoin absorption in man." Br J Clin Pharmacol 20 (1985): 238-40. [PMID: 3840029]
44 Product Information. Bonefos (clodronate). Rhone-Poulenc Rorer Canada Inc, Laval, QC.
45 Product Information. Boniva (ibandronate). Roche Laboratories, Nutley, NJ.
46 Product Information. Skelid (tilundronate). Sanofi Winthrop Pharmaceuticals, New York, NY.
47 Weissman I, Krivoy N "Interaction of aluminum hydroxide and allopurinol in patients on chronic hemodialysis." Ann Intern Med 107 (1987): 787. [PMID: 3662305]
48 Product Information. Xofluza (baloxavir marboxil). Genentech, South San Francisco, CA.
49 Product Information. Chenodal (chenodeoxycholic acid). Manchester Pharmaceutical, Fort Collins, CO.
50 Product Information. Cholbam (cholic acid). Manchester Pharmaceutical, Fort Collins, CO.
51 Product Information. Exjade (deferasirox). Novartis Pharmaceuticals, East Hanover, NJ.
52 Product Information. Ferriprox (deferiprone). ApoPharma USA Inc, Rockville, MD.
53 Rey AM, Gums JG "Altered absorption of digoxin, sustained-release quinidine, and warfarin with sucralfate administration." DICP 25 (1991): 745-6. [PMID: 1949932]
54 Multum Information Services, Inc. Expert Review Panel.
55 Darcy PF "Nutrient-drug interactions." Adverse Drug React Toxicol Rev 14 (1995): 233-54. [PMID: 8845456]
56 Product Information. Actonel (risedronate). Procter and Gamble Pharmaceuticals, Cincinnati, OH.
57 Product Information. Fosamax (alendronate). Merck & Co, Inc, West Point, PA.
58 Product Information. NegGram (nalidixic acid). Sanofi Winthrop Pharmaceuticals, New York, NY.
59 Haagsma CJ "Clinically important drug interactions with disease-modifying antirheumatic drugs." Drugs Aging 13 (1998): 281-9. [PMID: 9805209]
60 Harkness JA, Blake DR "Penicillamine nephropathy and iron." Lancet 2 (1982): 1368-9. [PMID: 6129465]
61 Joyce DA "D-penicillamine pharmacokinetics and pharmacodynamics in man." Pharmacol Ther 42 (1989): 405-27. [PMID: 2672052]
62 Lyle WH "Penicillamine and iron." Lancet 2 (1976): 420. [PMID: 73880]
63 Netter P, Bannwarth B, Pere P, Nicolas A "Clinical pharmacokinetics of D-penicillamine." Clin Pharmacokinet 13 (1987): 317-33. [PMID: 3319347]
64 Osman MA, Patel RB, Schuna A, Sundstrom WR, Welling PG "Reduction in oral penicillamine absorption by food, antacid and ferrous sulfate." Clin Pharmacol Ther 33 (1983): 465-70. [PMID: 6831825]
65 Product Information. Cuprimine (penicillamine). Merck & Co, Inc, West Point, PA.
66 Product Information. Fosamax (alendronate). Merck &amp Co, Inc, West Point, PA.
67 D'Arcy PF, McElnay JC "Drug-antacid interactions: assessment of clinical importance." Drug Intell Clin Pharm 21 (1987): 607-17. [PMID: 2886325]
68 McElnay JC, Temple DJ. The use of buccal partitioning as a model to examine the effects of aluminium hydroxide gel on the absorption of propranolol. Br J Clin Pharmacol. 1982;13(3):399-403. [PMID: 7059441]
69 Gugler R, Allgayer H "Effects of antacids on the clinical pharmacokinetics of drugs. An update." Clin Pharmacokinet 18 (1990): 210-9. [PMID: 1969784]
70 Hong CY, Hu SC, Lin SJ, Chiang BN "Lack of influence of aluminum hydroxide on the bioavailability and beta-adrenoceptor blocking activity of propranolol." Int J Clin Pharmacol Ther Toxicol 23 (1985): 244-6. [PMID: 4008113]
71 Kirch W, Schafer-Korting M, Axthelm T, Kohler H, Mutschler E "Interaction of atenolol with furosemide and calcium and aluminum salts." Clin Pharmacol Ther 30 (1981): 429-35. [PMID: 7285476]
72 Laer S, Neumann J, Scholz H "Interaction between sotalol and an antacid preparation." Br J Clin Pharmacol 43 (1997): 269-72. [PMID: 9088581]
73 Regardh CG, Lundborg P, Persson BA "The effect of antacid, metoclopramide, and propantheline on the bioavailability of metoprolol and atenolol." Biopharm Drug Dispos 2 (1981): 79-87. [PMID: 7236872]
74 Havrankova J, Lahaie R "Levothyroxine binding by sucralfate." Ann Intern Med 117 (1992): 445-6. [PMID: 1503346]
75 Khan F, Jeanniton E, Renedo M "Does sucralfate impede levothyroxine therapy?" Ann Intern Med 118 (1993): 317. [PMID: 8481187]
76 Covington TR, Lawson LC, Young LL, eds. "Handbook of Nonprescription Drugs. 10th ed." Washington, DC: American Pharmaceutical Association (1993):.
77 Fann WE "Interactions of psychotropic drugs in the elderly." Postgrad Med 53 (1973): 182-6. [PMID: 4144160]
78 Romankiewicz JA "Effects of antacids on gastrointestinal absorption of drugs." Prim Care 3 (1976): 537-50. [PMID: 61596]
79 Fann WE, Davis JM, Janowsky DS, Sekerke HJ, Schmidt DM "Chlorpromazine: effects of antacids on its gastrointestinal absorption." J Clin Pharmacol 13 (1973): 388-90. [PMID: 4355737]
80 Forrest FM, Forrest IS, Serra MT "Modification of chlorpromazine metabolism by some other drugs frequently administered to psychiatric patients." Biol Psychiatry 2 (1970): 53-8. [PMID: 5414905]
81 Pedrazzoli Junior J, Pierossi M de A, Muscara MN, Dias HF, da Silva CM, Mendes FD, de Nucci G "Short-term sucralfate administration alters potassium diclofenac absorption in healthy male volunteers." Br J Clin Pharmacol 43 (1997): 104-8. [PMID: 9056060]
82 Product Information. Dolobid (diflunisal). Merck & Co, Inc, West Point, PA.
83 Verbeeck R, Tjandramaga TB, Mullie A, Verbesselt R, de Schepper PJ "Effect of aluminum hydroxide on diflunisal absorption." Br J Clin Pharmacol 7 (1979): 519-22. [PMID: 314299]
84 Hava M, Hurwitz A "The relaxing effect of aluminum and lanthanum on rat and human gastric smooth muscle in vitro." Eur J Pharmacol 156 (1973): 156-61. [PMID: 4715218]
85 Hurwitz A, Schlozman DL "Effects of antacids on gastrointestional absorption of isoniazid in rat and man." Am Rev Respir Dis 109 (1974): 41-7. [PMID: 4588090]
86 Carver PL, Berardi RR, Knapp MJ, Rider JM, Kauffman CA, Bradley SF, Atassi M "In vivo interaction of ketoconazole and sucralfate in healthy volunteers." Antimicrob Agents Chemother 38 (1994): 326-9. [PMID: 7910724]
87 Hoeschele JD, Roy AK, Pecoraro VL, Carver PL "In vitro analysis of the interaction between sucralfate and ketoconazole." Antimicrob Agents Chemother 38 (1994): 319-25. [PMID: 7910723]
88 Piscitelli SC, Goss TF, Wilton JH, D'Andrea DT, Goldstein H, Schentag JJ "Effects of ranitidine and sucralfate on ketoconazole bioavailability." Antimicrob Agents Chemother 35 (1991): 1765-71. [PMID: 1952845]
89 Canadian Pharmacists Association.
90 Product Information. Naprosyn (naproxen). Syntex Laboratories Inc, Palo Alto, CA.
91 Wohlt PD, Zheng L, Gunderson S, Balzar SA, Johnson BD, Fish JT "Recommendations for the use of medications with continuous enteral nutrition." Am J Health Syst Pharm 66 (2009): 1438-67. [PMID: 19667002]